treat
The first CRISPR therapy approved in the U.S. will treat sickle cell disease
U.S. patients with sickle cell disease now have a novel treatment option: the first-ever CRISPR-based therapy. On December 8, the U.S. Food and Drug Administration approved the gene-editing therapy for use in patients age 12 years and older. In addition to offering hope of relief for people with severe forms of the painful blood disorder,…
Removing zombie-like cells may help treat multiple sclerosis
Senolytic drugs can clear away worn and damaged “zombie” immune cells that are resistant to dying, which may help treat multiple sclerosis, according to research in mice Source link